Conceptus, Inc. (NASDAQ:CPTS)

CAPS Rating: 3 out of 5

The Company develops, manufactures and markets the Essure(r) permanent birth control system, an innovative and proprietary medical device for women.

Featured Broker Partners


Advertisement